
    
      The randomized clinical trial is to investigate and compare the effectiveness of CAD-guided
      low-dose computed tomography and low-dose computed tomography in lung cancer screening for
      community individuals in Shanghai, China. Thus, an imaging protocol which can detect early
      lung cancer in asymptomatic high risk patients will be proposed.
    
  